Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Menke

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Genome Biology|May 25, 2018
Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signalingAnthony S Zannas, Janine Arloth, Tania Carrillo-Roa, et al.
Archives of General Psychiatry|September 9, 2009
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionMarcus Ising, Susanne Lucae, Elisabeth B Binder, et al.
Genome Biology|December 18, 2015
Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signalingAnthony S Zannas, Janine Arloth, Tania Carrillo-Roa, et al.
Comprehensive Psychiatry|April 12, 2024
When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)Susan Brown, Cornelia Ploeger, Boliang Guo, et al.
Neuron|June 8, 2015
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric DisordersJanine Arloth, Ryan Bogdan, Peter Weber, et al.
Trials|November 25, 2017
The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trialJonathan Kingslake, Rebecca Dias, Gerard R Dawson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trialMichael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 24, 2023
Deep phenotyping as a contribution to personalized depression therapy: the GEParD and DaCFail protocolsKatharina Lichter, Catherina Klüpfel, Saskia Stonawski, et al.
Neuron|April 28, 2011
The neuronal transporter gene SLC6A15 confers risk to major depressionMartin A Kohli, Susanne Lucae, Philipp G Saemann, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Genome Biology|May 25, 2018
Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signalingAnthony S Zannas, Janine Arloth, Tania Carrillo-Roa, et al.
Archives of General Psychiatry|September 9, 2009
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionMarcus Ising, Susanne Lucae, Elisabeth B Binder, et al.
Genome Biology|December 18, 2015
Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signalingAnthony S Zannas, Janine Arloth, Tania Carrillo-Roa, et al.
Comprehensive Psychiatry|April 12, 2024
When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)Susan Brown, Cornelia Ploeger, Boliang Guo, et al.
Neuron|June 8, 2015
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric DisordersJanine Arloth, Ryan Bogdan, Peter Weber, et al.
Trials|November 25, 2017
The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trialJonathan Kingslake, Rebecca Dias, Gerard R Dawson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trialMichael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 24, 2023
Deep phenotyping as a contribution to personalized depression therapy: the GEParD and DaCFail protocolsKatharina Lichter, Catherina Klüpfel, Saskia Stonawski, et al.
Neuron|April 28, 2011
The neuronal transporter gene SLC6A15 confers risk to major depressionMartin A Kohli, Susanne Lucae, Philipp G Saemann, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Pageof 6